Mexiletine Hydrochloride Capsule
Product Images NDC 62756-955

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mexiletine Hydrochloride (NDC 62756-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Spl-mexiletine-150 mg (Spl Mexiletine 150 mg)

Spl-mexiletine-150 mg (Spl Mexiletine 150 mg)
Mexiletine Hydrochloride Capsules are prescribed to treat chronic pain from nerve damage. Each capsule contains 150mg of Mexiletine hydrochloride, which is the main active ingredient used to manage neuropathic pain. The recommended dosage should be followed as per the package insert. It is advised to take this medicine with food or antacid as it may cause stomach upset. Store the medicine in a tightly closed, child-resistant container at controlled room temperature. Keep this and all medications away from the reach of children. This medicine is distributed by Sun Pharmaceutical Industries and sold by Aavis Pharmaceuticals.*
FDA Label Image

Spl-mexiletine-200 mg (Spl Mexiletine 200 mg)

Spl-mexiletine-200 mg (Spl Mexiletine 200 mg)
Mexiletine Hydrochloride Capsules are available in 200 mg strength and should be taken with food or antacid. Each capsule contains 200 mg of Mexiletine hydrochloride, USP. The exact dosage has been mentioned in the package insert or full prescribing information. These capsules should be stored at a temperature of 20° to 25°C (68°F 1o 7°F) excursions permitted o 15°C 10 30°C (S9°F o 86°F). To ensure quality, they must also be dispensed in light-resistant containers with child-resistant closures as defined by the USP. The manufacturer advises keeping Mexiletine Hydrochloride Capsules and all medications out of reach of children. These capsules are manufactured by Aavis Pharmaceuticals, Hoschton, and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury. However, the document does not specify the indication for the medication.*
FDA Label Image

Spl-mexiletine-250 mg (Spl Mexiletine 250 mg)

Spl-mexiletine-250 mg (Spl Mexiletine 250 mg)
Mexiletine Hydrochloride is a medication available in capsule form, containing 250mg Mexletie hydrochloride, USP. The usual dosage is listed on the package insert or full prescribing information. It is recommended to take this medication with food or an antacid. The capsules should be stored between 20°C to 25°C (68°F to 7°F), with excursions permitted between 15°C to 30°C (59°F to 86°F) as stated by USP Controlled Room Temperature. Dispense in a light-resistant container that meets the USP standards, with a child-resistant closure. Keeping this medication and all other medications out of reach of children is advisable. The manufacturer of the medication is Aavis Pharmaceuticals, and it is distributed by Sun Pharmaceutical Indust, Granbury, I 0851. If any confusion arises, consulting the prescribing physician or pharmacist is recommended.*
FDA Label Image

Spl-mexiletine-structure (Spl Mexiletine Structure)

Spl-mexiletine-structure (Spl Mexiletine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.